By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending the 2017 Marcum MicroCap Conference on June 15-16 at the Grand Hyatt New York. Integrium helps micro-cap and small-cap biotechs attain clinical data so they can raise their next round of capital. Many current and prospective clients reach out to Integrium to discuss alternative financing solutions. Integrium executives look forward to meeting with prospective companies in the life science and healthcare sectors, as well as engaging in featured presentations of CEOs and CFOs.
Year after year, the Marcum MicroCap Conference has consistently provided publicly traded companies with less than $500 million in market capitalization the chance to network with the investment community. The conference consists of a full itinerary of expert panels on important topics related to the investment field. The event draws fund managers and high net worth investors who concentrate on small-cap equities.
Some of the industries that presenting companies are involved in are Life Sciences and Healthcare, Financial and Asset Management Services, Software and Business Services, and Retail and Consumer Products. The 2017 key note speakers for the conference are involved in various industries such as politics, economics, and finance.
About Integrium
Through a trusted partnership with PoC Capital, Integrium is able to assist micro- cap, small-cap, and privately held biotechs looking to raise additional financing, by providing new clinical data to create the next bump in valuation. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.
Check out our new website!
Contact
To learn more about Integrium, contact:
Emily MacHale
Associate Director of Marketing & Research
Emily.MacHale@Integrium.com
908-375-2009
